Nutraceuticals, defined as food products that provide health benefits beyond basic nutrition, are increasingly recognized for their potential role in managing diabetes. Compounds such as omega-3 fatty acids, curcumin, berberine, and cinnamon have shown promise in research for their ability to improve insulin sensitivity, regulate blood glucose levels, and reduce inflammation. Incorporating these natural agents into a comprehensive diabetes management plan can complement traditional therapies and enhance patient outcomes. For example, omega-3 fatty acids are known to promote cardiovascular health, while curcumin has anti-inflammatory properties that may benefit metabolic function. However, it is essential for patients to consult healthcare providers before introducing new supplements to their routines, ensuring safety and efficacy. Educating patients about the potential benefits and appropriate use of nutraceuticals can empower them to make informed decisions about their health. Ultimately, while nutraceuticals are not replacements for conventional diabetes treatments, they can play a valuable adjunctive role in promoting overall well-being and effective management of diabetes.










Title : Changes in the global incidence of diabetes over a quarter century
F Buck Willis, Christian College of Medicine
Title : Vascular health with glucagon-like peptide-1 receptor agonists
Mahir Khalil Ibrahim Jallo, Thumbay University Hospital
Title : The prowess of Overripe Banana Sweetener (OBS) in enhancing nutritive values in food and ameliorating glycaemic responses in type 2 diabetes mellitus
Wan Rosli Wan Ishak, Universiti Sains Malaysia
Title : Wound care 2.0 creating a wound care culture TM
David Navazio, Gentell
Title : Association between diabetes technology use and prevalent macrovascular disease in adults with type 1 diabetes: A cross-sectional analysis
Divanshi Trivedi, London Northwest Hospital NHS Foundation Trust
Title : Beyond the prescription: Using GLP 1 science and lifestyle coaching to prevent prediabetes and support long term blood sugar control
Keith Hersey, Founder/CEO Destroying Diabetes
Title : Intensive versus standard blood pressure control in type 2 diabetes: Cardiovascular and microvascular outcomes
Muhammad Basil Raza, East Lancashire Hospitals NHS Trust
Title : Fetomaternal outcomes in gestational diabetes mellitus with and without polycystic ovary syndrome
Vinita Singh, AIIMS
Title : Effects of a structured education program on glycemic control in type 1 diabetes
Ana Paula Franco Pacheco, Estacio University of Brasília
Title : Cardiorespiratory fitness inflammatory and neurotrophic biomarkers and cognitive function in early versus longer duration type 2 diabetes mellitus
Arbind Kumar Choudhary, All India Institute of Medical Sciences